Eye-tracking parameters as biomarkers of frontotemporal dementia

Eye-tracking parameters as biomarkers of frontotemporal dementia - Eye-tracking in FTD (FTDEYE)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON51509

Enrollment

136

Registered

2022-10-28

Start date

2022-10-31

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease Frontotemporal dementia

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) Patients with FTD referred to our referral center and diagnosed with use of International Consensus Criteria. The dementia symptoms have to be mild (clinical dementia rating

Exclusion criteria

Exclusion criteria: Subjects with a previous stroke or other (neurological) conditions that may affect cognitive functions (brain tumour, multiple sclerosis, use of psycho-active medications) will be excluded from participation in this study.

Design outcomes

Primary

Measure	Time frame
Eye movement features derived from the eye-tracking test battery.	—

Countries

Netherlands

Outcome results